0001567619-18-006486.txt : 20181115
0001567619-18-006486.hdr.sgml : 20181115
20181115174048
ACCESSION NUMBER: 0001567619-18-006486
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181113
FILED AS OF DATE: 20181115
DATE AS OF CHANGE: 20181115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kaufmann Mark
CENTRAL INDEX KEY: 0001611184
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36485
FILM NUMBER: 181188166
MAIL ADDRESS:
STREET 1: C/O ARDELYX, INC.
STREET 2: 34175 ARDENWOOD BLVD, SUITE 100
CITY: FREMONT
STATE: CA
ZIP: 94555
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARDELYX, INC.
CENTRAL INDEX KEY: 0001437402
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 34175 ARDENWOOD BLVD.
CITY: FREMONT
STATE: CA
ZIP: 94555
BUSINESS PHONE: 510-745-7047
MAIL ADDRESS:
STREET 1: 34175 ARDENWOOD BLVD.
CITY: FREMONT
STATE: CA
ZIP: 94555
FORMER COMPANY:
FORMER CONFORMED NAME: NTERYX INC
DATE OF NAME CHANGE: 20080611
4
1
doc1.xml
FORM 4
X0306
4
2018-11-13
0
0001437402
ARDELYX, INC.
ARDX
0001611184
Kaufmann Mark
C/O ARDELYX, INC.
34175 ARDENWOOD BLVD, SUITE 200
FREMONT
CA
94555
0
1
0
0
Chief Financial Officer
Common Stock
2018-11-13
4
S
0
6539
2.84
D
146489
D
Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
This transaction was executed in multiple trades in prices ranging from $2.81 to $2.84, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Includes 1,642 shares acquired under the Issuer's Employee Stock Purchase Plan on August 31, 2018.
/s/ Elizabeth Grammer, Attorney-in-Fact for Mark Kaufmann
2018-11-15